| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/24/1993 | WO1993011746A1 Inhalation powders and method of manufacturing them |
| 06/24/1993 | WO1993011743A1 Medicaments |
| 06/24/1993 | WO1993011668A1 Methods and compositions for reducing multi-drug resistance |
| 06/24/1993 | WO1993010163A3 Adhesive hydrogels having extended use lives and process for the preparation of same |
| 06/24/1993 | WO1993009762A3 Method for extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents |
| 06/24/1993 | CA2654849A1 Fluorocarbon aerosol medicaments |
| 06/24/1993 | CA2126101A1 Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr) |
| 06/24/1993 | CA2125975A1 Further improvements relating to the radiolabelling of proteins |
| 06/24/1993 | CA2125400A1 Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation |
| 06/24/1993 | CA2125279A1 Methods and compositions for reducing multi-drug resistance |
| 06/24/1993 | CA2124672A1 Cytokines with an upaired cysteine residue and conjugates thereof |
| 06/24/1993 | CA2123780A1 Amphotericin b composition with enhanced antifungal activity |
| 06/24/1993 | CA2122585A1 Transdermal azidothymidine |
| 06/24/1993 | CA2117332A1 Glycosylated steroid acid derivatives for transport across biological membranes and process for making same |
| 06/23/1993 | WO1993011757A1 Drug formulations for parenteral use |
| 06/23/1993 | EP0547688A1 Sustained release tablets |
| 06/23/1993 | EP0547654A1 Contrast agents for ultrasound imaging |
| 06/23/1993 | EP0547422A2 Stable powdery vitamin and/or carotinoid preparations and process for their production |
| 06/23/1993 | EP0547229A1 External preparation containing cyclosporin |
| 06/23/1993 | EP0547163A1 Protein polyligands joined to a stable protein core |
| 06/23/1993 | EP0547137A1 Homoconjugated immunoglobulins |
| 06/23/1993 | EP0547126A1 Polymers containing diester units. |
| 06/23/1993 | EP0528978A4 Controlled release dopamine and its use to stimulate nerve fiber growth |
| 06/23/1993 | EP0272278B1 $i(D)-GL CONJUGATE THERAPY |
| 06/23/1993 | CN1073359A Lipophilic oligosaccharide antibiotics composite |
| 06/23/1993 | CN1073358A Improved freeze drying isocyclophosphamide composite |
| 06/22/1993 | US5221735 Polyenes lycopene or apocarotenal, soluble in water, alcohol or water/alcohol mixture |
| 06/22/1993 | US5221722 Crosslinked polyacrylic acid |
| 06/22/1993 | US5221698 Bioactive composition |
| 06/22/1993 | US5221696 Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs |
| 06/22/1993 | US5221695 Aqueous formulation containing a piperidinylcyclopentylheptenoic acid derivative and beta-cyclodextrin |
| 06/22/1993 | US5221534 Health and beauty aid compositions |
| 06/22/1993 | US5221286 Nonionic cream mixture of water, oxidizer and emulsifier in continuous phase and salt of fatty acid ester of lactylic acid, saturated monoglyceride and saturated fatty acid monoester of propylene glycol in discontinuous phase |
| 06/22/1993 | CA2085810A1 Pharmaceutical and feedstuff premixes |
| 06/22/1993 | CA1319321C Pharmaceutical preparations |
| 06/21/1993 | CA2085799A1 Compositions for the treatment of mammalian diseases |
| 06/21/1993 | CA2085782A1 Polyaspartamide derivatives as adsorbents for bile acids, polyaspartamide derivatives loaded with bile acids and process for their preparation and their use as pharmaceuticals |
| 06/20/1993 | WO1993011753A1 Solvent system to be enclosed in capsules |
| 06/20/1993 | CA2085713A1 Pharmaceutical compositions for peroral administration |
| 06/20/1993 | CA2085690A1 Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation |
| 06/19/1993 | WO1993011751A1 Lubricous polymer network |
| 06/19/1993 | CA2100970A1 Lubricous polyer network |
| 06/17/1993 | WO1993012111A1 Novel cocaine derivatives and protein and polypeptide cocaine derivative conjugates and labels |
| 06/17/1993 | DE4140689A1 Inhalationspulver und verfahren zu ihrer herstellung Inhalation powder and process for their production |
| 06/17/1993 | DE4140172A1 Retardform fuer ein ibuprofen enthaltendes arzneimittel und seine herstellung Release form for an ibuprofen-containing drug and its manufacture |
| 06/16/1993 | EP0547000A1 Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor compound |
| 06/16/1993 | EP0546939A1 Biodegradable magnetic microclusters and methods for making them |
| 06/16/1993 | EP0546810A1 Carboxyvinyl polymer having Newtonian viscosity |
| 06/16/1993 | EP0546593A1 Multi-layered compositions containing histamine or serotonin antagonists |
| 06/16/1993 | EP0546122A1 Inhibition of metastasis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies |
| 06/16/1993 | EP0486499A4 Stable ascorbic acid compositions |
| 06/16/1993 | EP0352295B1 Biodadhesion drug carriers for endothelial and epithelial uptake and lesional localization of therapeutic and diagnostic agents |
| 06/16/1993 | CN1073094A Pharmaceutical composition containing felbinac |
| 06/16/1993 | CN1021226C Preparation for acyl derivatives |
| 06/15/1993 | US5220014 Inhibit protein synthesis |
| 06/15/1993 | US5219877 Fungicide. antiinflammatory agents |
| 06/15/1993 | US5219870 Antiulcer agents |
| 06/15/1993 | US5219853 Water miscible concentrated basic solution of active agent in propylene glycol or polyethylene glycol with triethanolamine or arginine |
| 06/15/1993 | US5219764 Hapten-biotin conjugates and their use |
| 06/15/1993 | US5219746 Ice-mediated introduction of substances into biological material |
| 06/15/1993 | US5219580 Thermoplastic silicone shaped articles for controlled release of iodine values to domestic water supplies |
| 06/15/1993 | US5219577 Biologically active composition having a nanocrystalline core |
| 06/15/1993 | US5219571 Applying bentonite dispersed in lipophilic agent |
| 06/15/1993 | US5219564 Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon |
| 06/15/1993 | US5219563 Contacting synthetic cation exchange resin with ranitidine or salt to form complex |
| 06/15/1993 | US5219328 Fibrin sealant delivery method |
| 06/15/1993 | CA2085200A1 Pharmaceutical composition |
| 06/15/1993 | CA1319110C Pharmaceutical composition comprising exifone and water-soluble polymer |
| 06/15/1993 | CA1319109C Spray dried ibuprofen |
| 06/15/1993 | CA1319108C Drug delivery devices |
| 06/15/1993 | CA1319107C Formulations for inhibiting glucose transport |
| 06/15/1993 | CA1319106C Antacid composition |
| 06/15/1993 | CA1319105C Antifungal gel formulations |
| 06/15/1993 | CA1319104C Skin permeation enhancer compositions using sucrose esters |
| 06/15/1993 | CA1319101C Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules |
| 06/15/1993 | CA1319100C Immunochemical detection of hypoxia in normal and tumor tissue |
| 06/14/1993 | CA2085149A1 Carboxyvinyl polymer having newtonian viscosity |
| 06/14/1993 | CA2084970A1 Biodegradable magnetic microclusters and methods for making them |
| 06/13/1993 | WO1993011776A1 Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by o-glycosylation modification |
| 06/13/1993 | CA2124565A1 Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by o-glycosylation modification |
| 06/13/1993 | CA2085142A1 Stabilized pharmaceutical composition of non glycosyled recombinant human il2 in reduced form and preparation process therefore |
| 06/10/1993 | WO1993011253A1 Cell-free ciliary neurotrophic factor/receptor complex |
| 06/10/1993 | WO1993011220A1 Medical preparations |
| 06/10/1993 | WO1993011147A1 Dna encoding a human 5-ht1e receptor and uses thereof |
| 06/10/1993 | WO1993011120A1 Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
| 06/10/1993 | WO1993011105A1 Leukotriene-b4 derivatives, process for preparing the same and medicaments |
| 06/10/1993 | WO1993010819A1 Process for the preparation of transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates |
| 06/10/1993 | WO1993010809A1 Fibronectin-containing ophthalmic solution, method of manufacture of an ophthalmic solution, method of preserving an ophthalmic solution, and methods of treatment of ophthalmic wounds |
| 06/10/1993 | WO1993010797A1 Dimeticon pastilles |
| 06/10/1993 | WO1993010794A1 Composition and method for improving oral bioavailability of carbamazepine |
| 06/10/1993 | WO1993010775A1 Process and composition for the development of controlled release gemfibrozil dosage form |
| 06/10/1993 | WO1993010770A1 Slow-release medicament containing a dihydropyridine derivate as a nanosol and its preparation |
| 06/10/1993 | WO1993010769A1 Slow-release pharmaceutic form of a medicament containing 3-indolylacetic acid derivate and its preparation |
| 06/10/1993 | WO1993010766A1 Immediate-effect flurbiprofen-containing medicament and its use |
| 06/10/1993 | WO1993010763A1 Antitumor vaccines |
| 06/10/1993 | WO1993010760A1 Slow-release ibuprofen-containing medicament and its use |
| 06/10/1993 | WO1993010743A2 Controlled use of polyether-substituted tumor agents in diagnosis and therapy |
| 06/10/1993 | CA2123677A1 Process and composition for the development of controlled release gemfibrozil dosage form |
| 06/10/1993 | CA2123307A1 Process for the preparation of transferrin receptor specific antibody-neuro-pharmaceutical or diagnostic agent conjugates |
| 06/10/1993 | CA2122992A1 Leukotriene-b derivatives, process for preparing the same and medicaments |